New concepts in organ site research on medulloblastoma: Genetics and genomics

Future Oncology

Volumn 6, Issue 8, 2010, Pages 1229-1231

  Roussel, Martine F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; HEDGEHOG ANTAGONIST; ITRACONAZOLE; MICRORNA; SOMATOMEDIN; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER GENETICS; CANCER GROWTH; CANCER MODEL; CANCER RESEARCH; CANCER STEM CELL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MEDULLOBLASTOMA; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALS; BIOMEDICAL RESEARCH; CEREBELLAR NEOPLASMS; GENOMICS; HUMANS; MEDULLOBLASTOMA; MICE; SIGNAL TRANSDUCTION;

EID: 77956315717     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.10.86     Document Type: Conference Paper

References (9)

1. Fernandez LA, Northcott PA, Dalton J et al.: YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 23(23), 2729-2741 (2009).
2. Yang ZJ, Ellis T, Markant SL et al.: Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14 (2). 135-145 (2008).
3. Swartling FJ, Grimmer MR, Hackett CS et al.: Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 24(10), 1059-1072 (2010).
4. Dubuc AM, Northcott PA, Mack S, Witt H, Pfister S, Taylor MD: The genetics of pediatric brain tumors. Curr. Neurol. Neurosci. Rep. 10(3), 215-223 (2010).
5. Thompson MC, Fuller C, Hogg TL et al.: Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J. Clin. Oncol. 24(12), 1924-1931 (2006).
6. Pfister S, Remke M, Benner A et al.: Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J. Clin. Oncol. 27(10), 1627-1636 (2009).
7. Yauch RL, Dijkgraaf GJ, Alicke B et al.: Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326(5952), 572-574 (2009).
8. Von Hoff DD, LoRusso PM, Rudin CM et al.: Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J Med. 361(12), 1164-1172 (2009).
9. Kim J, Tang JY, Gong R et al.: Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 17(4), 388-399 (2010).